Live Breaking News & Updates on Molecular Stethoscope Technology Platform

(1)
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology
PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/NASH patients with clinically relevant and advanced liver fibrosis using the company s Next-Generation cell-free mRNA Liquid Biopsy Technology Platform. The study titled Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization was published in the
American Journal of Physiology -
Gastrointestinal and Liver Physiology, a journal of the American Physiological Society. The first author is Naga Chalasani, M.D., Professor of Gastroenterology and Hepatology and Interim Chair in the Department of Medicine at Indiana University in the USA. Dr. Chalasani is the leading author of the AASLD Practice Guidelines for th ....

Stanford University , United States , Stephen Quake , Guillermo Elias , Chan Zuckerberg Biohub , Kostenloser Wertpapierhandel , Veronica Miller , Naga Chalasani , Eric Topol , Scripps Research Translational Institute , Uc Berkeley School Of Public Health , Technology Platform , Prnewswire Molecular Stethoscope Inc , Drug Development Tools , Molecular Stethoscope Technology Platform , Forum For Collaborative Research , United States National Institute Of Standards , Rna Liquid Biopsy Technology Platform , Liver Forum , Professor Of Bioengineering At Stanford University , American Physiological Society , Artificial Intelligence Technology Platform , Department Of Medicine At Indiana University , Biopsy Technology , Non Alcoholic Fatty Liver Disease , Whole Transcriptome Cell Free ,